These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 1083601)

  • 21. [Etofenamate (Rheumon gel). Quickly effective, risk-reduced rheumatism therapy through cutaneous application].
    ZFA (Stuttgart); 1980 May; 56(13):939-41. PubMed ID: 6968132
    [No Abstract]   [Full Text] [Related]  

  • 22. [Evaluation of the therapeutic action of flufenamic acid in patients with chronic polyarthritis in a double blind study].
    Mathies H; Eichhorn M
    Med Monatsschr; 1967 Nov; 21(11):510-6. PubMed ID: 4893773
    [No Abstract]   [Full Text] [Related]  

  • 23. [Experience with a locally applicable antirheumatic (author's transl)].
    Klug H
    Arzneimittelforschung; 1977; 27(6B):1350-4. PubMed ID: 336057
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Therapeutic use of clofezone in rheumatic diseases].
    Vitaus M; Franovic A; Dürrigl T
    Schweiz Rundsch Med Prax; 1973 Jan; 62(3):78-82. PubMed ID: 4282506
    [No Abstract]   [Full Text] [Related]  

  • 25. [Treatment of rheumatic diseases of soft tissues with Mobilisin Gel. Results of a double-blind study].
    Hohmeister R
    Fortschr Med; 1983 Sep; 101(35):1586-8. PubMed ID: 6226579
    [No Abstract]   [Full Text] [Related]  

  • 26. [The new anti-inflammatory acids. Niflumic acid in rheumatology].
    Camus JP
    Presse Med (1893); 1968 May; 76(22):1071-2. PubMed ID: 5300745
    [No Abstract]   [Full Text] [Related]  

  • 27. [Corticosteroid containing antirheumatic combination drugs in the treatment of rheumatic diseases. Effect and tolerance of a dexamethasone containing drug in a stable therapeutic 10 day plan].
    Kratzsch G; Raptis S; Pal SB; Fehm HL; Pfeiffer EF
    Fortschr Med; 1978 Oct; 96(39):2001-4. PubMed ID: 308922
    [No Abstract]   [Full Text] [Related]  

  • 28. Advances in the treatment of rheumatic disorders.
    Dick WC; Buchanan WW
    Practitioner; 1971 Oct; 207(240):483-91. PubMed ID: 4943697
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparison of a salicylate-heparin gel with a monosubstance preparation. Results of a double-blind cross-over study].
    Geller O
    MMW Munch Med Wochenschr; 1980 Sep; 122(36):1231-2. PubMed ID: 6777681
    [No Abstract]   [Full Text] [Related]  

  • 30. Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study.
    Kapadia L; Elder MG
    Lancet; 1978 Feb; 1(8060):348-50. PubMed ID: 75392
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Treatment of rheumatic diseases with Sigma-Elmedal under spa-conditions].
    Engel P
    Fortschr Med; 1974 Feb; 92(6):254-6. PubMed ID: 4544747
    [No Abstract]   [Full Text] [Related]  

  • 32. [Results of topical therapy with Etofenamat in rheumatic diseases and sports injuries. Report on a seminar on Etofenamat (Rheumon Gel) during the 28th German Congress for Continuing Medical Education, 5-9 June 1979 in Berlin].
    Fortschr Med; 1979 Sep; 97(36):(1586). PubMed ID: 40852
    [No Abstract]   [Full Text] [Related]  

  • 33. [Experimental results of combinations of nonsteroid anti-inflammatory agents in acute and chronic inflammation].
    Tamisier JN; Lamarche M; Pourel J; Louyot P
    Rev Rhum Mal Osteoartic; 1974 Mar; 41(3):163-71. PubMed ID: 4843055
    [No Abstract]   [Full Text] [Related]  

  • 34. Discussion on clinical trials of the fenamates.
    Ann Phys Med; 1966; Suppl():129-34. PubMed ID: 5306340
    [No Abstract]   [Full Text] [Related]  

  • 35. [Our 1st experiences with Butazolidin Alka 100 tablets].
    Franović A
    Reumatizam; 1974 Jan; 21(1):8-10. PubMed ID: 4594966
    [No Abstract]   [Full Text] [Related]  

  • 36. [Association of a new analgesic with phenylbutazone in rheumatic diseases].
    Fellet AJ; Meyer JA
    Hospital (Rio J); 1966 Oct; 70(4):1009-15. PubMed ID: 5301478
    [No Abstract]   [Full Text] [Related]  

  • 37. [Clinical trial of the new percutaneously active antirheumatic etofenamate. Summarising report (author's transl)].
    Heindl I; Lorenz D; Sieberns S; Blumberger W
    Arzneimittelforschung; 1977; 27(6B):1357-63. PubMed ID: 144509
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Percluson (Clophezon)--clinical drug evaluation].
    Wysocka K; Szwed L
    Pol Tyg Lek; 1973 Nov; 28(48):1902-3. PubMed ID: 4543746
    [No Abstract]   [Full Text] [Related]  

  • 39. [Clinical trial of the association of phenylbutazone and paracetamol in extra-articular rheumatism].
    Gamarski J
    Hospital (Rio J); 1966 Sep; 70(3):675-8. PubMed ID: 5300275
    [No Abstract]   [Full Text] [Related]  

  • 40. [Clinical experiences with a new phenylbutazone preparation: Alka-Butazolidine].
    Porzio F; Tuzi T
    Rass Int Clin Ter; 1972 May; 52(10):583-90. PubMed ID: 4537829
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.